Roșian Andreea, Zdrîncă Mihaela, Dobjanschi Luciana, Vicaș Laura Grațiela, Mureșan Mariana Eugenia, Dindelegan Camelia Maria, Platona Rita Ioana, Marian Eleonora
Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
Department of Preclinical Discipline, Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania.
Pharmaceuticals (Basel). 2025 May 25;18(6):792. doi: 10.3390/ph18060792.
Depression is a widespread and complex disorder, constituting a major public health concern due to its significant impact on mental health. Because of the limitations of major depressive disorder (MDD) treatment, recent research on depression management has focused on identifying new therapeutic strategies. The effects of vitamin D on the brain, mediated through various mechanisms, suggest the potential implication of vitamin D in the pathophysiology of depression. In this systematic review, our objective was to evaluate the correlation between serum levels of 25-hydroxyvitamin D (25(OH)D) and depression based on evidence from cross-sectional and cohort studies. Furthermore, we also assessed the effect of vitamin D supplementation in relation to depressive symptoms, using data from randomised controlled trials (RCTs). To achieve the proposed objective, we have compiled a report that includes a selection of empirical evidence necessary to review the relationship between vitamin D and depression. In this regard, relevant articles were searched on platforms such as PubMed, MDPI, ResearchGate, Springer Link, Springer Open, and ScienceDirect. A total of 13,976 records, published between 2008 and 2024, were initially identified through database searches. After the study selection process, performed according to the PRISMA guidelines, 70 articles were included in the systematic review. According to most cross-sectional and cohort studies, the results highlight an inverse relationship between serum 25(OH)D levels and the risk of depression, as well as the severity of depressive symptoms. An increase in serum 25(OH)D concentration is associated with an improvement in depression test scores, with vitamin D supplementation exerting a beneficial effect on both the incidence and the prognosis of depression. Based on current evidence which indicates the implications of vitamin D in the neurobiological mechanisms associated with depression, and the results obtained in most of the studies, which demonstrate an inverse relationship between serum 25(OH)D levels and the beneficial effect of vitamin D supplementation on depressive symptoms, vitamin D could represent an adjunctive therapy in the management of MDD. More rigorous studies, without methodological errors, are needed to correctly and definitively assess the impact of vitamin D in relation to depression.
抑郁症是一种广泛存在且复杂的疾病,因其对心理健康有重大影响而成为主要的公共卫生问题。由于重度抑郁症(MDD)治疗存在局限性,近期关于抑郁症管理的研究集中在寻找新的治疗策略。维生素D通过多种机制对大脑产生影响,这表明维生素D可能参与了抑郁症的病理生理过程。在本系统评价中,我们的目的是基于横断面研究和队列研究的证据,评估血清25-羟基维生素D(25(OH)D)水平与抑郁症之间的相关性。此外,我们还利用随机对照试验(RCT)的数据,评估了补充维生素D对抑郁症状的影响。为实现上述目标,我们编撰了一份报告,其中包括一系列用于审视维生素D与抑郁症之间关系的实证证据。为此,我们在PubMed、MDPI、ResearchGate、Springer Link、Springer Open和ScienceDirect等平台上检索了相关文章。通过数据库检索,最初共识别出2008年至2024年间发表的13976条记录。按照PRISMA指南进行研究筛选后,70篇文章被纳入本系统评价。根据大多数横断面研究和队列研究结果,血清25(OH)D水平与抑郁症风险及抑郁症状严重程度之间呈负相关。血清25(OH)D浓度升高与抑郁测试分数的改善相关联,补充维生素D对抑郁症的发病率和预后均有有益影响。基于目前表明维生素D参与抑郁症相关神经生物学机制的证据,以及大多数研究所得出的血清25(OH)D水平与补充维生素D对抑郁症状有益影响之间呈负相关的结果,维生素D可能是MDD管理中的一种辅助治疗方法。需要开展更多无方法学错误的严谨研究,以正确且明确地评估维生素D对抑郁症的影响。